Editor-in-Chief Of ESMO Rare Cancers, a New, Online, Open Access Journal from ESMO
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
Kian-Huat Lim, MD, PhD, discusses the importance of multidisciplinary collaboration when diagnosing and treating patients with pancreatic cancer.
Craig Eckfeldt, MD, PhD, discusses key updates in the MDS treatment paradigm and the implications of MRD testing, as well as next steps in the…
S. Vincent Rajkumar, MD, discusses highly anticipated abstracts in multiple myeloma that will be presented at the 2024 ASCO Annual Meeting.
An abstract is unavailable.
Two biosimilars for reference denosumab have received marketing authorization from the European Commission.
Did you know that drinking alcohol can affect your cancer risk, lead to long-term health issues and impact your microbiome, sleep and brain function? Our…
Stephen V. Liu, MD, discusses studies being presented at the 2024 ASCO Annual Meeting that may provide valuable insights into the management of NSCLC.
Stephanie Graff, MD, FACP, FASCO, Brown University, Providence, RI, discusses the latest findings from the NATALEE (NCT03701334) and monarchE (NCT03155997) trials, focusing on the efficacy…
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Carrie L. Kitko, MD, discusses the current standing of cellular therapies in adult and pediatric ALL and looks toward future developments.